DK1165138T3 - Programmeret, kontrolleret ovarial stimulationsprotokol ved anvendelse af orale svangerskabsforebyggende midler - Google Patents

Programmeret, kontrolleret ovarial stimulationsprotokol ved anvendelse af orale svangerskabsforebyggende midler

Info

Publication number
DK1165138T3
DK1165138T3 DK00920521T DK00920521T DK1165138T3 DK 1165138 T3 DK1165138 T3 DK 1165138T3 DK 00920521 T DK00920521 T DK 00920521T DK 00920521 T DK00920521 T DK 00920521T DK 1165138 T3 DK1165138 T3 DK 1165138T3
Authority
DK
Denmark
Prior art keywords
programmed
oral contraceptives
stimulation protocol
ovarian stimulation
controlled ovarian
Prior art date
Application number
DK00920521T
Other languages
English (en)
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Application granted granted Critical
Publication of DK1165138T3 publication Critical patent/DK1165138T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00920521T 1999-03-31 2000-03-21 Programmeret, kontrolleret ovarial stimulationsprotokol ved anvendelse af orale svangerskabsforebyggende midler DK1165138T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12724199P 1999-03-31 1999-03-31
US13163299P 1999-04-28 1999-04-28
PCT/EP2000/002466 WO2000059542A1 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol

Publications (1)

Publication Number Publication Date
DK1165138T3 true DK1165138T3 (da) 2004-08-30

Family

ID=26825471

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920521T DK1165138T3 (da) 1999-03-31 2000-03-21 Programmeret, kontrolleret ovarial stimulationsprotokol ved anvendelse af orale svangerskabsforebyggende midler

Country Status (28)

Country Link
US (1) US8173592B1 (da)
EP (1) EP1165138B1 (da)
JP (1) JP4616999B2 (da)
KR (1) KR100679880B1 (da)
CN (1) CN1346281B (da)
AR (1) AR023249A1 (da)
AT (1) ATE265862T1 (da)
AU (1) AU768544B2 (da)
BG (1) BG65270B1 (da)
BR (1) BR0009477A (da)
CA (1) CA2367214C (da)
CO (1) CO4970741A1 (da)
CZ (1) CZ299820B6 (da)
DE (1) DE60010452T2 (da)
DK (1) DK1165138T3 (da)
ES (1) ES2219331T3 (da)
HK (1) HK1044892B (da)
HU (1) HU229252B1 (da)
IL (2) IL145630A0 (da)
MX (1) MXPA01009862A (da)
NO (1) NO327210B1 (da)
NZ (1) NZ514964A (da)
PL (1) PL199569B1 (da)
PT (1) PT1165138E (da)
RU (1) RU2226395C2 (da)
SK (1) SK287244B6 (da)
TW (1) TWI241194B (da)
WO (1) WO2000059542A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
MEP14008A (en) * 2003-02-21 2010-06-10 Bayer Schering Pharma Ag Uv stable transdermal therapeutic plaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
KR20080041662A (ko) * 2005-07-22 2008-05-13 다케다 야쿠힌 고교 가부시키가이샤 조기 배란 예방제
RU2641606C2 (ru) * 2012-11-09 2018-01-18 Иасомай АБ N-ацетил-L-цистеин для применения в экстракорпоральном оплодотворении
KR102473092B1 (ko) 2014-09-15 2022-12-01 칠드런'즈 메디컬 센터 코포레이션 히스톤 h3-리신 트리메틸화를 제거함으로써 체세포 핵 이식(scnt) 효율을 증가시키는 방법 및 조성물
HUE054300T2 (hu) * 2015-04-17 2021-08-30 Ferring Bv FSH-t tartalmazó, meddõség kezelésére szolgáló készítmény
MA46353A (fr) 2016-09-30 2019-08-07 Myovant Sciences Gmbh Méthodes de traitement de l'infertilité féminine
RU2665967C1 (ru) * 2017-06-14 2018-09-05 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ стимуляции роста фолликулов в программах экстракорпорального оплодотворения у пациенток с бесплодием различного генеза и "бедным ответом на стимуляцию"
CN107982520A (zh) * 2017-12-25 2018-05-04 上海交通大学医学院附属第九人民医院 外源性MPA与hMG在制备动物模型药物中的应用
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
CN113456801A (zh) * 2021-08-05 2021-10-01 浙江大学医学院附属第四医院 人绒毛膜促性腺激素在制备早发性卵巢功能不全患者的助孕药物中的应用
KR102821987B1 (ko) * 2024-10-24 2025-06-26 에이디텍 주식회사 베타 코어 단편 hCG를 유효성분으로 포함하는 난임 치료용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
EP0161063B1 (en) * 1984-04-03 1991-07-24 Serono Laboratories, Inc. Method of inducing ovulation
EP0462189B1 (en) 1989-03-10 1995-09-27 Endorecherche Inc. Combination therapy for treatment of estrogen sensitive diseases
RU2005459C1 (ru) * 1991-04-24 1994-01-15 Анисимова Тамара Ивановна Способ лечения эндокринного бесплодия у женщин
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
SK282118B6 (sk) 1994-07-22 2001-11-06 The Medical College Of Hampton Roads Použitie antagonistu hormónu uvoľňujúceho gonadotropíny
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2200541C (en) 1997-01-22 2013-02-19 Philippe Bouchard Lhrh-antagonists in the treatment of fertility disorders
WO1998058647A1 (en) * 1997-06-23 1998-12-30 Mcneil-Ppc Acetaminophen and cisapride analgesics
CZ301912B6 (cs) * 1998-04-23 2010-07-28 Zentaris Ivf Gmbh Lécivo na lécení neplodnosti nitrodeložní inseminací

Also Published As

Publication number Publication date
PL351327A1 (en) 2003-04-07
KR20010105401A (ko) 2001-11-28
WO2000059542A1 (en) 2000-10-12
AR023249A1 (es) 2002-09-04
MXPA01009862A (es) 2003-10-14
SK287244B6 (sk) 2010-04-07
NZ514964A (en) 2003-08-29
CN1346281B (zh) 2010-04-14
US8173592B1 (en) 2012-05-08
CN1346281A (zh) 2002-04-24
HUP0200431A2 (hu) 2002-07-29
ES2219331T3 (es) 2004-12-01
IL145630A0 (en) 2002-06-30
JP2002541122A (ja) 2002-12-03
CZ299820B6 (cs) 2008-12-03
CZ20013495A3 (cs) 2002-06-12
ATE265862T1 (de) 2004-05-15
CA2367214A1 (en) 2000-10-12
EP1165138B1 (en) 2004-05-06
BR0009477A (pt) 2002-01-08
AU768544B2 (en) 2003-12-18
HUP0200431A3 (en) 2004-04-28
CA2367214C (en) 2008-07-29
NO20014736D0 (no) 2001-09-28
RU2226395C2 (ru) 2004-04-10
DE60010452D1 (de) 2004-06-09
PT1165138E (pt) 2004-09-30
HU229252B1 (en) 2013-10-28
HK1044892B (zh) 2011-06-30
KR100679880B1 (ko) 2007-02-07
DE60010452T2 (de) 2005-04-14
EP1165138A1 (en) 2002-01-02
NO20014736L (no) 2001-11-26
NO327210B1 (no) 2009-05-11
AU4106900A (en) 2000-10-23
HK1044892A1 (en) 2002-11-08
SK13842001A3 (sk) 2002-09-10
BG106045A (en) 2002-05-31
TWI241194B (en) 2005-10-11
PL199569B1 (pl) 2008-10-31
CO4970741A1 (es) 2000-11-07
IL145630A (en) 2009-09-01
JP4616999B2 (ja) 2011-01-19
BG65270B1 (bg) 2007-11-30
WO2000059542A9 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
DE69923594D1 (de) Flammhemmende, mikroporöse materialien
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
PT1444215E (pt) Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina
ATE370120T1 (de) Substituierte 2-pyridin-cyclohexan-1,4- diaminderivate
DE60143412D1 (de) Oberfräse
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
FI20001578L (fi) QoS-arkkitehtuuri
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
DE60110792D1 (de) Paketkommunikationssystem
FR2792264B1 (fr) Mecanisme de reglage irreversible
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20022503L (no) Römmersko
ATE289796T1 (de) Orale zusammensetzung
DE60010606D1 (de) Verschluss
DE60109646D1 (de) Ethernet-anpassungsvorrichtung
ATE265862T1 (de) Programmierte ovarielle stimulationsbehandlungprotokoll unter verwendung von oralen kontrazeptiva
DK1223887T3 (da) Implantatindstilling
DE60018492D1 (de) Drehwinkel-Verstelleinheit
FI20020695A7 (fi) Spatiaalisesti kytketty reititin langattomia datapaketteja varten
FI20000342A0 (fi) Verkonhallintajärjestelmä
ID28945A (id) Turunan-turunan 3-(benzalol-7-il)-ih-pirimidin-2,4-dion
DE50100088D1 (de) Irisblende
DE60040589D1 (de) Paketübertragung
IT1310127B1 (it) Smorzatore oscillante controllato.
DE60024023D1 (de) Nockenwellenversteller